Hagan Mark Christopher 4/A

What Happened
Mark Christopher Hagan, AMN Healthcare’s Chief Information and Digital Officer, had Restricted Stock Units (RSUs) vest on January 15, 2026, resulting in the acquisition of 36,828 shares of AMN common stock. To cover tax withholding, 4,139 shares were surrendered at $19.55 per share (total withholding ≈ $80,917), leaving a net of about 32,689 shares. The gross value of the vested shares at $19.55 was about $719,987; net value after withholding was about $639,070. The filing has been amended to correct the reported beneficial ownership (36,828 shares following the transaction).

Key Details

• Transaction date: January 15, 2026. Price used for tax withholding: $19.55/share.
• Gross shares vested/awarded (A): 36,828 shares.
• Shares withheld for taxes (F): 4,139 shares (591 + 926 + 2,622) → cash value ≈ $80,917.
• Net shares received: ~32,689 shares.
• Shares beneficially owned after transaction (as amended): 36,828 shares (footnote F10 corrects prior overstatement).
• Relevant codes: A = award/grant (RSU vesting); M = exercise/conversion of derivative (conversion of RSUs to shares); F = shares withheld for tax liability.
• Footnotes: RSUs granted under AMN equity plans with multi-year vesting schedules (grants referenced from 2023–2026). The Form 4 was amended to correct an earlier overstatement of derivative securities; the original Form 4 (filed Jan 16) overstated post-transaction beneficial ownership.

Context

• These were vested RSUs converting into common stock, with shares withheld to satisfy tax obligations (a routine, non-open-market event).
• This is an award/vesting event rather than a cash purchase or an open-market sale; such vesting reflects compensation and does not by itself signal insider buying conviction.
• The amendment corrects reported ownership figures; no indication here of late reporting beyond the corrective amendment.